Product
RAIN-32
Aliases
Milademetan
2 clinical trials
19 indications
Indication
Dedifferentiated LiposarcomaIndication
Solid TumorsIndication
Head and Neck CarcinomaIndication
CholangiocarcinomaIndication
SarcomaIndication
Adenocarcinoma of the LungIndication
Bladder Urothelial CarcinomaIndication
Stomach AdenocarcinomaIndication
Breast CancerIndication
Ovarian CancerIndication
Cervical CancerIndication
Lung CancerIndication
Stomach CancerIndication
Bile Duct CancerIndication
MelanomaIndication
Pancreatic CancerIndication
MDM2 Gene AmplificationIndication
Testicular Germ Cell TumorIndication
Adrenocortical CancerClinical trial
A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients With Dedifferentiated LiposarcomaStatus: Terminated, Estimated PCD: 2023-10-01
Clinical trial
A Phase 2 Basket Study of Milademetan in Advanced/Metastatic Solid Tumors (MANTRA-2)Status: Terminated, Estimated PCD: 2023-10-15